PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

Major changes are coming to the Wilmington International Airport. ILM will be home to a new temperature-controlled ...

The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

Because CRM is widely applicable across industries and is primed to benefit from the expansion of AI, companies in this ...